[Nucleic acids in hepato-cerebral dystrophy].
D000293:Adolescent; D000328:Adult; D002614:Chelating Agents / Q000627:therapeutic use; D004247:DNA / Q000032:analysis / Q000097:blood*; D005260:Female; D005947:Glucose / Q000627:therapeutic use; D006527:Hepatolenticular Degeneration / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D008099:Liver / Q000032:analysis*; D008297:Male; D008433:Mathematics; D008875:Middle Aged; D010396:Penicillamine / Q000627:therapeutic use; D010743:Phospholipids / Q000097:blood; D010758:Phosphorus / Q000097:blood; D012313:RNA / Q000032:analysis / Q000097:blood*; D013438:Sulfhydryl Compounds / Q000627:therapeutic use; D014803:Vitamin B Complex / Q000627:therapeutic use
D002614:Chelating Agents; D010743:Phospholipids; D013438:Sulfhydryl Compounds; D014803:Vitamin B Complex; D010758:Phosphorus; D012313:RNA; D004247:DNA; D010396:Penicillamine; D005947:Glucose
Nukleinovye kisloty pri gepato-tserebral'noĭ distrofii.